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abstract
Periodontal medicine has been studied and reviewed ex-
tensively since its introduction to the dental fraternity. The 
association of periodontal disease with and its effects on 
the cardiovascular system are amongst the many topics ex-
plored. A summary of the research into these associations 
and the possible mechanisms of any relationship is present-
ed. Although a link between these two chronic inflammatory 
diseases is evident, the very heterogeneity of the relevant 
studies has not provided evidence sufficient to support an 
actual causal relationship. More stringent epidemiologic and 
intervention studies are required.
IntroductIon
“Periodontal medicine”, as defined by Williams and Offenbacher 
in 2000, has initiated a wealth of research which has explored 
the potential that periodontitis may induce effects on other sys-
tems distant from the oral cavity.1 The term was coined to de-
scribe these systemic effects that were already being explored 
and had been reported on in the preceding decade or two. The 
question thus arose, as enunciated by Miller as early as 1891, 
“do oral infections have effects on distant body systems?” 2 
initial acceptance of the concept resulted in the widespread 
practice of untoward and unwarranted dental extractions.3 To 
this day prophylactic antibiotics are still prescribed, by some, 
in susceptible cardiac patients, with the intention of the pre-
vention of infective endocarditis. Such practice lends recogni-
tion to the “focus of infection” theory of old.
 
The literature abounds with research which has investigated 
the association between periodontitis and cardiovascular dis-
eases. Several observational, cross sectional and interven-
tion studies, as well as reviews, have been published. This 
paper considers the current evidence for the association.
Gingivitis and periodontitis are the two most  common forms 
of periodontal diseases affecting the majority of the popula-
tion, with a prevalence rate of up to approximately 90%  col-
lectively.4 Gingivitis is the mildest form of the two, limited to the 
gingivae, whilst periodontitis involves the attachment appara-
tus inclusive of alveolar bone loss, the hallmark of periodonti-
tis. This is accompanied by loss of gingival connective tissue 
attachment. Periodontitis is an irreversible and chronic inflam-
matory disease initiated by periodontopathic bacteria, but in 
addition the susceptibility of the host and the initiation of an 
immune response play an essential role in its pathogenesis. 
Clinically it is characterised by inflammatory changes of the 
gingivae, deep pocketing around teeth, loss of clinical attach-
ment and radiographic evidence of alveolar bone loss. The 
result is gingival recession. Soft and hard deposits on teeth, 
supra- and sub-gingivally, are usually seen and contribute to 
the destructive process. Tooth mobility and/or migration is 
seen in persons with advanced periodontitis.4 
Cardiovascular disease similarly presents a spectrum of 
pathologies that affect the heart and circulatory system. 
Atherosclerosis is the common platform from which all other 
clinical cardiovascular modalities arise, including ischaemic 
heart disease, cerebrovascular disease and also disease 
of the peripheral circulation. Lack of early diagnosis and or 
failure in management can predispose potentially fatal acute 
events, including myocardial infarction, stroke and acute 
coronary syndromes.2, 5, 6 Survivors of such episodes are 
often left with devastating effects on their quality of life.
 
Cardiovascular disease is the second most common cause 
of death worldwide. in South Africa, 14.7% of reported deaths 
are attributed to diseases of the circulatory system.7 The 
global trend is somewhat higher, with approximately 30% of 
all deaths caused by atherosclerotic vascular disease.8 The 
difference between the national and global trend is related to 
the impact of the HiV/AiDS epidemic in South Africa.
 
Uncontrolled cardiovascular disease imposes a significant 
burden on the sufferer, particularly affecting his/her quality 
of life. Prevention and management of acute events such 
as myocardial infarction and strokes have significant financial 
implications. These costly preventive measures are required 
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acronYMs
CRP:  C-Reactive Protein 
HbA1c:  glycosolated haemoglobin molecule 
HSP:  Heat Shock Proteins 
ICAM-1: intercellular Adhesion Molecule-1 
IL-6:  interleukin-6 
Pg :  Porphyromonas gingivalis
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to improve the quality of life and to prolong life expectancy.
The current global prevalence of periodontitis is not well de-
fined but in its severe form is reported to range from 5-15%.9 
Most of the available data are from the developed world. The 
prevalence rates reported from diverse countries are dif-
ficult to compare as markedly variable study designs were 
employed. Furthermore no standardised means of disease 
measurement was employed.
  
coMMon ground between 
perIodontItIs and cardIovascular 
dIsease
Both periodontitis and cardiovascular disease have a mul-
tifactorial aetiology. They share an array of risk factors.2 
Environmental and lifestyle risk factors may or may not be 
modifiable. These include increasing age, smoking, alcohol 
abuse, ethnicity, socio-economic status, male sex, diabetes 
mellitus (hyperglycaemia and insulin resistance), obesity and 
genetic predisposition.2, 10, 11
 
Various theories have been investigated to explain the asso-
ciation between periodontitis and cardiovascular disease. One 
theory proposed that the chronicity of moderate to severe 
forms of periodontitis elicits a systemic inflammatory response 
sufficient to affect the inflammatory pathogenesis of athero-
sclerosis.2, 3, 11, 12, 13 A second theory is that the bacteraemia of 
periodontal pathogenic species arises via ulcerations of the 
junctional epithelium. This process is proposed to occur espe-
cially in persons of compromised immunity.2, 3, 11, 12 A third, more 
complex mechanism is one of autoimmunity,11 specifically the 
cross-reactivity of the host to periodontal pathogens such as 
Porphyromonas gingivalis (Pg). The antibodies directed at peri-
odontal bacterial lipopolysaccharide cross-react with host en-
dothelial components and thereby accelerate the atherogenic 
process. Endothelial damage has been reported due to the 
immune response to bacterial heat shock proteins (HSP).2, 14
atherosclerosIs
The process of atherosclerosis is paramount in the patho-
genesis of cardiovascular disease and thus a basic under-
standing is essential. Atherosclerosis itself comprises a ma-
jor part of cardiovascular disease. The inflammatory events 
elicited by periodontal infections are purported to contribute 
continually toward atherogenesis.11 Commonality for both 
diseases exists in the induction of inflammatory events, 
which incite increased vascular inflammation.
Atheromas form as a result of continual inflammation inflicted 
upon the vascular endothelium. Risk factors such as hyperten-
sion, high-saturated fat diet, obesity, hyperglycemia and insulin 
resistance perpetuate this sustained inflammatory state within 
the vascular endothelium. This enhances the expression of en-
dothelial cell adhesion molecules, resulting in atheroma forma-
tion. When the atheroma becomes unstable or is physically 
disrupted, acute cardiovascular events ensue.11
     
the role of perIodontopathIc 
bacterIa
Periodontitis has a well-established bacterial aetiology.15 Peri-
odontopathic bacteria include amongst others: P gingivalis 
(Pg), Tannerella forsythia (Tf ) and Aggregatibacter actinomyc-
etemcomitans (Aa).4 infection in a susceptible host by these 
putative pathogens elicits the release of an arsenal of weaponery 
such as leukotoxins, collagenases and proteases. Their pres-
ence precipitates an immune response that may be the means 
by which the atherogenic process is stimulated. These well-es-
tablished periodontal pathogens have also been isolated from 
atheromatous plaques of the coronary circulation, aortic and heart 
valves.5, 16, 17, 18 One such organism, Pg, has been found not only 
to invade both endothelial and epithelial cells, but also to contribute 
towards platelet aggregation,11, 19, 20 the latter being a key feature in 
the development of atheromas (as described above). The immune 
response to the antigenic challenge presented by Pg also causes 
what has been described as molecular mimicry.2 This process is 
known for the cross-reactivity of autoantibodies in response to Pg 
antigens, resulting in endothelial damage via host endothelial heat 
shock proteins.14
perIodontal InterventIon 
and surrogate Markers of 
cardIovascular dIsease 
Numerous workers have investigated the association of 
periodontitis and cardiovascular disease by examining 
the levels of known surrogate markers of cardiovascular 
disease in patients with periodontitis. These biomarkers 
include: intima medial thickness of carotid vasculature, 
flow mediated dilatation of the brachial artery, high den-
sity lipoprotein, low density lipoprotein, cholesterol fibrino-
gen, high sensitivity C-reactive protein (CRP), glycosolated 
haemoglobin molecule (HbA1c) and blood pressure.5, 6 An 
elevation of the occurrence of these markers is known to 
occur in periodontitis.21 intervention studies investigating 
the effect of periodontal treatment on surrogate markers 
have been extensively reviewed.22
C-reactive protein (CRP), a product of the liver, is released in 
response to infection and trauma. it has been established as 
a marker for the development of recurrent ischaemic events 
in patients with unstable angina (cited by Ouyang et al in 
2011).22 CRP has proved to be the strongest and most inde-
pendent predictor of incipient cardiovascular disease.11 CRP 
is increased in other acute cardiac events such as myo-
cardial infarction and in chronic coronary heart disease. it 
has been shown that patients with periodontitis have higher 
concentrations of CRP.23 Furthermore, reviews and meta-
analysis have reported a statistically significant improvement 
in CRP levels after periodontal treatment.22, 23
 
Marked improvements in lipid profiles were found in patients 
after periodontal treatment, with an additional beneficial ef-
fect when adjunctive antibiotics were used. A significant ef-
fect was seen only in patients with elevated lipid profiles at 
baseline, and not in patients with lipid profiles within normal 
parameters or already controlled by medication.22
Periodontal disease has been shown to be associated with 
elevated serum pro-inflammatory cytokines.21 Some inter-
vention studies have shown a post-treatment reduction in 
the levels of pro-inflammatory cytokines, which are involved 
in the pathogenesis of both periodontitis and cardiovascu-
lar disease. interleukin-1, interleukin-6 (iL-6), interleukin-8, 
tumour necrosis factor–α, intercellular adhesion molecule-1 
(iCAM-1), p-Selectin and E-selectin are included, but an 
even greater body of evidence exists reporting a reduction 
of serum iL-6 following periodontal intervention in persons 
with cardiovascular disease.22, 24
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A key step in atherogenesis is endothelial dysfunction, which is 
seen in persons with periodontitis.22 Studies have consistently 
shown that periodontal treatment reduces endothelial dysfunc-
tion in periodontitis patients who are systemically healthy. En-
dothelial dysfunction is measured by brachial flow mediated 
dilation, a surrogate marker of cardiovascular disease.25
intimal medial thickness of coronary vasculature is a measure of 
cardiovascular health and of subclinical atherosclerosis.26 Work-
ers such as Cairo et al have found that severe periodontitis is as-
sociated with subclinical atherosclerosis in a young population.26 
Other studies have found that this surrogate marker shows re-
covery or is reduced in a subset of patients who received peri-
odontal intervention (cited in Ouyang et al 2011).22
conclusIon
The periodontitis-cardiovascular link is complex and difficult to 
define. The literature has provided sufficient evidence for there 
being an association between these two chronic inflammatory 
diseases. There remains controversy on some levels as to a 
cause- and effect relationship. A recent editorial (SADJ Feb-
ruary 2012) eloquently presents the dilemma and proposes 
that, whilst the evidence may not be precise in refuting the 
cause and effect relationship, nevertheless is able to support 
the association between the diseases.27 The paradox, already 
noted, is that these chronic diseases share common risk fac-
tors. These confounding factors make it difficult to interpret with 
confidence the outcomes of studies of different design.28 Ob-
servational studies, by the nature of their design, are especially 
prone to bias.28 intervention studies have looked at the effect of 
periodontal treatment on different parameters of cardiovascular 
disease. Given that the expression of some of the surrogate 
markers of cardiovascular disease were improved (CRP and 
iL-6) with periodontal intervention, nonetheless it is recognised 
that these parameters do not act in isolation as promoters of 
the pathogenesis of cardiovascular disease. The heterogene-
ity which characterises the available intervention studies (study 
design, duration, selection criteria, different end points or out-
comes) is evident also in the  disparities amongst the observed 
results.22 Epidemiologic studies as well as more stringently 
controlled intervention studies are required to determine the 
long term effect of periodontal intervention on cardiovascular 
disease outcomes and quality of life.
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